Sheldon L. Koenig
Net Worth
Last updated:
What is Sheldon L. Koenig net worth?
The estimated net worth of Mr. Sheldon L. Koenig is at least $3,170,672 as of 17 Dec 2024. He owns shares worth $1,502,055 as insider, has earned $145,697 from insider trading and has received compensation worth at least $1,522,920 in Esperion Therapeutics, Inc..
What is the salary of Sheldon L. Koenig?
Mr. Sheldon L. Koenig salary is $507,640 per year as Pres, Chief Executive Officer & Director in Esperion Therapeutics, Inc..
How old is Sheldon L. Koenig?
Mr. Sheldon L. Koenig is 59 years old, born in 1966.
What stocks does Sheldon L. Koenig currently own?
As insider, Mr. Sheldon L. Koenig owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Esperion Therapeutics, Inc. (ESPR) | Pres, Chief Executive Officer & Director | 739,819 | $2.03 | $1,502,055 |
What does Esperion Therapeutics, Inc. do?
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.
Sheldon L. Koenig insider trading
Esperion Therapeutics, Inc.
Mr. Sheldon L. Koenig has made 7 insider trades between 2022-2024, according to the Form 4 filled with the SEC. Most recently he sold 12,447 units of ESPR stock worth $30,694 on 17 Dec 2024.
The largest trade he's ever made was exercising 20,000 units of ESPR stock on 9 May 2023. As of 17 Dec 2024 he still owns at least 739,819 units of ESPR stock.
Esperion Therapeutics key executives
Esperion Therapeutics, Inc. executives and other stock owners filed with the SEC:
- Mr. Richard B. Bartram (43) Chief Financial Officer & Corporation Sec.
- Mr. Sheldon L. Koenig (59) Pres, Chief Executive Officer & Director